Using morning light therapy to treat postpartum depression
A Wearable Morning Light Treatment for Postpartum Depression: Confirming Efficacy and Mechanisms
This study is looking at how a special light device that you can wear in the morning might help new moms feel better if they're dealing with postpartum depression, making it easier for them to improve their mood without taking medication.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11001739 on NIH RePORTER |
What this research studies
This research investigates the effectiveness of a wearable morning light treatment for women suffering from postpartum depression, a common condition affecting new mothers. The approach focuses on using bright light therapy to help regulate circadian rhythms and improve mood without the need for medication. Participants will use the device at home, making it accessible and convenient for new mothers who may have difficulty accessing traditional treatments. The study aims to confirm the therapy's efficacy and understand how it works in the context of postpartum depression.
Who could benefit from this research
Good fit: Ideal candidates for this research are women experiencing postpartum depression who are seeking non-medication-based treatment options.
Not a fit: Patients who are not experiencing postpartum depression or those who prefer traditional pharmacological treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a non-pharmacological treatment option for postpartum depression, improving the mental health of new mothers.
How similar studies have performed: Previous research has shown that bright light therapy can be effective for various types of depression, suggesting potential for success in this novel application.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Swanson, Leslie M — University of Michigan at Ann Arbor
- Study coordinator: Swanson, Leslie M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.